2014
DOI: 10.1039/c4cc07511k
|View full text |Cite
|
Sign up to set email alerts
|

Toll-like receptor agonist lipopeptides self-assemble into distinct nanostructures

Abstract: The self-assembled structure of toll-like receptor agonist lipopeptides containing the CSK4 peptide sequence is examined in aqueous solution. A remarkable dependence of morphology on the number of attached hexadecyl lipid chains is demonstrated, with spherical micelle structures for mono- and di-lipidated structures observed, but flexible wormlike micelles for the homologue containing three lipid chains. The distinct modes of assembly may have an important influence on the bioactivity of this class of lipopept… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

15
57
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 47 publications
(72 citation statements)
references
References 31 publications
15
57
0
Order By: Relevance
“…Briefly, cells (1 ϫ 10 6 cells/experimental condition; 2 ϫ 10 6 cells/ml) were stimulated with anti-CD3 (clone OKT3; 5 g/ml) and anti-CD28 (clone 9.3; 2 g/ml) MAbs in the absence or presence of prewarmed (40°C) TLR2 agonist Pam3CSK4 (10 g/ml) for 30 min at 37°C under a 5% CO 2 atmosphere. The TLR2 ligand was subjected to a heat treatment to reduce its natural ability to adopt a self-assembled nanostructure (91). Cells next were fixed in 1 ml of 2% paraformaldehyde for 20 min at 4°C before being stained with PE-Cy7-conjugated anti-human CCR6 in 200 l of PBS-2 mM EDTA-0.5% BSA for 15 min at room temperature under dark conditions.…”
Section: Ethicsmentioning
confidence: 99%
“…Briefly, cells (1 ϫ 10 6 cells/experimental condition; 2 ϫ 10 6 cells/ml) were stimulated with anti-CD3 (clone OKT3; 5 g/ml) and anti-CD28 (clone 9.3; 2 g/ml) MAbs in the absence or presence of prewarmed (40°C) TLR2 agonist Pam3CSK4 (10 g/ml) for 30 min at 37°C under a 5% CO 2 atmosphere. The TLR2 ligand was subjected to a heat treatment to reduce its natural ability to adopt a self-assembled nanostructure (91). Cells next were fixed in 1 ml of 2% paraformaldehyde for 20 min at 4°C before being stained with PE-Cy7-conjugated anti-human CCR6 in 200 l of PBS-2 mM EDTA-0.5% BSA for 15 min at room temperature under dark conditions.…”
Section: Ethicsmentioning
confidence: 99%
“…This toxicity occurs independent of their sequences or lengths [59] in a manner that is similar to the aggregation of Aβ in Alzheimer's disease [60] or α-synuclein in Parkinson's disease [61]. Previous studies showed that Pam3-Cys, the synthetic N-terminus of ospA, self-assembled and showed aggregating potential in vitro assays [58,62], which can be related to brain tissue damage including the disruption of synaptic function.…”
Section: Advances In Lipoprotein Researchmentioning
confidence: 92%
“…Lipopeptides, such as those incorporating the CSK 4 peptide motif and one, two or three palmitoyl (hexadecyl) chains [25], can also act as toll-like receptor (TLR) agonists, which have important applications in the treatment of disease. TLRs are transmembrane proteins that are very important in the immune system and as a result are therapeutic targets to treat disease.…”
Section: Toll-like Receptor Agonistsmentioning
confidence: 99%